What Researchers Did
French researchers followed 150 patients who needed a breathing machine during hyperbaric oxygen therapy over 6 years at one university hyperbaric centre and recorded how the sessions went.
What They Found
This prospective study of 150 mechanically ventilated patients (11 children and 139 adults) treated with hyperbaric oxygen therapy found that carbon monoxide poisoning (51%) and iatrogenic gas embolism (33%) were the two main reasons for intubation, and that the most common side effect, patient-ventilator asynchrony, occurred in 6 patients (5%). Midazolam with sufentanil was the most used sedation, given to 85 patients (67%). All patients received a bolus of a neuromuscular blocker during the session, including the 35 patients who had acute respiratory distress syndrome (ARDS). Mortality was higher in the ARDS group, at 23%.
What This Means for Canadian Patients
For people with carbon monoxide poisoning or gas embolism who are already on a ventilator, this study describes who received hyperbaric oxygen therapy in this setting and which side effects were seen. The authors concluded that mechanical ventilation was safe during these sessions in their study, and that sedation needs to be improved to avoid patient-ventilator asynchrony. The abstract also reports higher mortality in patients with ARDS, so these patients were a high-risk group.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study took place at a single French centre, had no comparison group of patients who were not ventilated, and mainly described side effects and outcomes, so it cannot show that the ARDS group's higher mortality was caused by anything related to the therapy itself.